Package 72657-168-50

Brand: olopatadine hydrochloride

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 72657-168-50
Digits Only 7265716850
Product NDC 72657-168
Product ID 72657-168_bc82a9d3-2fd3-4a7d-9126-c0f07a610b05
Description

1 BOTTLE, PLASTIC in 1 CARTON (72657-168-50) / 5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2024-07-26
Brand olopatadine hydrochloride
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

OLOPATADINE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "bc82a9d3-2fd3-4a7d-9126-c0f07a610b05", "openfda": {"upc": ["0372657168502"], "unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["a80c3fd2-47b7-4ed0-b862-9c5099684607"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (72657-168-50)  / 5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "72657-168-50", "marketing_start_date": "20240726"}], "brand_name": "OLOPATADINE HYDROCHLORIDE", "product_id": "72657-168_bc82a9d3-2fd3-4a7d-9126-c0f07a610b05", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "72657-168", "generic_name": "Olopatadine Hydrochloride ophthalmic", "labeler_name": "GLENMARK THERAPEUTICS INC., USA", "product_type": "HUMAN OTC DRUG", "brand_name_base": "OLOPATADINE HYDROCHLORIDE", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA200810", "marketing_category": "ANDA", "marketing_start_date": "20240726", "listing_expiration_date": "20271231"}